.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cerilliant
Chinese Patent Office
Cipla
Dow
QuintilesIMS
McKinsey
UBS
Citi
Novartis

Generated: February 22, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 08157800

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimGILOTRIFafatinib dimaleateTABLET;ORAL201292-001Jul 12, 2013RXYesNo➤ Try a Free Trial➤ Try a Free TrialY
Boehringer IngelheimGILOTRIFafatinib dimaleateTABLET;ORAL201292-002Jul 12, 2013RXYesNo➤ Try a Free Trial➤ Try a Free TrialY
Boehringer IngelheimGILOTRIFafatinib dimaleateTABLET;ORAL201292-003Jul 12, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist